Characterization of tumefactive demyelinating lesions using MR imaging and in-vivo proton MR spectroscopy

H. S. Malhotra, K. K. Jain, A. Agarwal, M. K. Singh, Santosh K. Yadav, M. Husain, N. Krishnani, Rakesh Kumar Gupta

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

Background and Objectives: Diagnosis of tumefactive demyelinating lesions (TDLs) is challenging to both clinicians and radiologists. Our objective in this study was to analyze and characterize these lesions clinically, biochemically, electrophysiologically, and on imaging. Methods: A retrospective analysis with prospective follow-up of 18 cases of TDLs was performed. Imaging included T2-, T1-weighted, fluid-attenuated inversion recovery (FLAIR), post-contrast T1-weighted, diffusion weighted imaging (DWI), and proton magnetic resonance spectroscopy (PMRS). Results: All the lesions appeared hyperintense on T2 and FLAIR images. Increased Apparent diffusion coefficient (ADC) (0.93-2.21 × 10-3 mm2/s) in centre of the lesion was seen in 14/18 cases; however, peripheral restriction (ADC values 0.55-0.64 × 10-3 mm2/s) was noted in 11/18 cases. In all, 13/18 cases showed contrast enhancement with open ring (n = 5), complete ring (n = 1), minimal (n = 4), and infiltrative (n = 3) pattern of enhancement. Nine of these 13 cases also showed venular enhancement. On PMRS, nine showed glutamate/glutamine (Glx) at 2.4 ppm. Conclusion: Clinical features along with several MRI characteristics such as open ring enhancement, peripheral restriction on DWI, venular enhancement, and presence of Glx on spectroscopy may be rewarding in differentiating TDLs from neoplastic lesions.

Original languageEnglish
Pages (from-to)193-203
Number of pages11
JournalMultiple Sclerosis
Volume15
Issue number2
DOIs
Publication statusPublished - 9 Feb 2009
Externally publishedYes

Fingerprint

Protons
Magnetic Resonance Spectroscopy
Glutamine
Glutamic Acid
Spectrum Analysis
Proton Magnetic Resonance Spectroscopy

Keywords

  • Apparent diffusion coefficient
  • Diffusion weighted imaging
  • Glutamate
  • Magnetic resonance imaging
  • Proton magnetic resonance spectroscopy
  • Tumefactive demyelinating lesions

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Characterization of tumefactive demyelinating lesions using MR imaging and in-vivo proton MR spectroscopy. / Malhotra, H. S.; Jain, K. K.; Agarwal, A.; Singh, M. K.; Yadav, Santosh K.; Husain, M.; Krishnani, N.; Gupta, Rakesh Kumar.

In: Multiple Sclerosis, Vol. 15, No. 2, 09.02.2009, p. 193-203.

Research output: Contribution to journalArticle

Malhotra, HS, Jain, KK, Agarwal, A, Singh, MK, Yadav, SK, Husain, M, Krishnani, N & Gupta, RK 2009, 'Characterization of tumefactive demyelinating lesions using MR imaging and in-vivo proton MR spectroscopy', Multiple Sclerosis, vol. 15, no. 2, pp. 193-203. https://doi.org/10.1177/1352458508097922
Malhotra, H. S. ; Jain, K. K. ; Agarwal, A. ; Singh, M. K. ; Yadav, Santosh K. ; Husain, M. ; Krishnani, N. ; Gupta, Rakesh Kumar. / Characterization of tumefactive demyelinating lesions using MR imaging and in-vivo proton MR spectroscopy. In: Multiple Sclerosis. 2009 ; Vol. 15, No. 2. pp. 193-203.
@article{01dc7a68e3da40f38582af933ec6f728,
title = "Characterization of tumefactive demyelinating lesions using MR imaging and in-vivo proton MR spectroscopy",
abstract = "Background and Objectives: Diagnosis of tumefactive demyelinating lesions (TDLs) is challenging to both clinicians and radiologists. Our objective in this study was to analyze and characterize these lesions clinically, biochemically, electrophysiologically, and on imaging. Methods: A retrospective analysis with prospective follow-up of 18 cases of TDLs was performed. Imaging included T2-, T1-weighted, fluid-attenuated inversion recovery (FLAIR), post-contrast T1-weighted, diffusion weighted imaging (DWI), and proton magnetic resonance spectroscopy (PMRS). Results: All the lesions appeared hyperintense on T2 and FLAIR images. Increased Apparent diffusion coefficient (ADC) (0.93-2.21 × 10-3 mm2/s) in centre of the lesion was seen in 14/18 cases; however, peripheral restriction (ADC values 0.55-0.64 × 10-3 mm2/s) was noted in 11/18 cases. In all, 13/18 cases showed contrast enhancement with open ring (n = 5), complete ring (n = 1), minimal (n = 4), and infiltrative (n = 3) pattern of enhancement. Nine of these 13 cases also showed venular enhancement. On PMRS, nine showed glutamate/glutamine (Glx) at 2.4 ppm. Conclusion: Clinical features along with several MRI characteristics such as open ring enhancement, peripheral restriction on DWI, venular enhancement, and presence of Glx on spectroscopy may be rewarding in differentiating TDLs from neoplastic lesions.",
keywords = "Apparent diffusion coefficient, Diffusion weighted imaging, Glutamate, Magnetic resonance imaging, Proton magnetic resonance spectroscopy, Tumefactive demyelinating lesions",
author = "Malhotra, {H. S.} and Jain, {K. K.} and A. Agarwal and Singh, {M. K.} and Yadav, {Santosh K.} and M. Husain and N. Krishnani and Gupta, {Rakesh Kumar}",
year = "2009",
month = "2",
day = "9",
doi = "10.1177/1352458508097922",
language = "English",
volume = "15",
pages = "193--203",
journal = "Multiple Sclerosis",
issn = "1352-4585",
publisher = "SAGE Publications Ltd",
number = "2",

}

TY - JOUR

T1 - Characterization of tumefactive demyelinating lesions using MR imaging and in-vivo proton MR spectroscopy

AU - Malhotra, H. S.

AU - Jain, K. K.

AU - Agarwal, A.

AU - Singh, M. K.

AU - Yadav, Santosh K.

AU - Husain, M.

AU - Krishnani, N.

AU - Gupta, Rakesh Kumar

PY - 2009/2/9

Y1 - 2009/2/9

N2 - Background and Objectives: Diagnosis of tumefactive demyelinating lesions (TDLs) is challenging to both clinicians and radiologists. Our objective in this study was to analyze and characterize these lesions clinically, biochemically, electrophysiologically, and on imaging. Methods: A retrospective analysis with prospective follow-up of 18 cases of TDLs was performed. Imaging included T2-, T1-weighted, fluid-attenuated inversion recovery (FLAIR), post-contrast T1-weighted, diffusion weighted imaging (DWI), and proton magnetic resonance spectroscopy (PMRS). Results: All the lesions appeared hyperintense on T2 and FLAIR images. Increased Apparent diffusion coefficient (ADC) (0.93-2.21 × 10-3 mm2/s) in centre of the lesion was seen in 14/18 cases; however, peripheral restriction (ADC values 0.55-0.64 × 10-3 mm2/s) was noted in 11/18 cases. In all, 13/18 cases showed contrast enhancement with open ring (n = 5), complete ring (n = 1), minimal (n = 4), and infiltrative (n = 3) pattern of enhancement. Nine of these 13 cases also showed venular enhancement. On PMRS, nine showed glutamate/glutamine (Glx) at 2.4 ppm. Conclusion: Clinical features along with several MRI characteristics such as open ring enhancement, peripheral restriction on DWI, venular enhancement, and presence of Glx on spectroscopy may be rewarding in differentiating TDLs from neoplastic lesions.

AB - Background and Objectives: Diagnosis of tumefactive demyelinating lesions (TDLs) is challenging to both clinicians and radiologists. Our objective in this study was to analyze and characterize these lesions clinically, biochemically, electrophysiologically, and on imaging. Methods: A retrospective analysis with prospective follow-up of 18 cases of TDLs was performed. Imaging included T2-, T1-weighted, fluid-attenuated inversion recovery (FLAIR), post-contrast T1-weighted, diffusion weighted imaging (DWI), and proton magnetic resonance spectroscopy (PMRS). Results: All the lesions appeared hyperintense on T2 and FLAIR images. Increased Apparent diffusion coefficient (ADC) (0.93-2.21 × 10-3 mm2/s) in centre of the lesion was seen in 14/18 cases; however, peripheral restriction (ADC values 0.55-0.64 × 10-3 mm2/s) was noted in 11/18 cases. In all, 13/18 cases showed contrast enhancement with open ring (n = 5), complete ring (n = 1), minimal (n = 4), and infiltrative (n = 3) pattern of enhancement. Nine of these 13 cases also showed venular enhancement. On PMRS, nine showed glutamate/glutamine (Glx) at 2.4 ppm. Conclusion: Clinical features along with several MRI characteristics such as open ring enhancement, peripheral restriction on DWI, venular enhancement, and presence of Glx on spectroscopy may be rewarding in differentiating TDLs from neoplastic lesions.

KW - Apparent diffusion coefficient

KW - Diffusion weighted imaging

KW - Glutamate

KW - Magnetic resonance imaging

KW - Proton magnetic resonance spectroscopy

KW - Tumefactive demyelinating lesions

UR - http://www.scopus.com/inward/record.url?scp=59349097409&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59349097409&partnerID=8YFLogxK

U2 - 10.1177/1352458508097922

DO - 10.1177/1352458508097922

M3 - Article

VL - 15

SP - 193

EP - 203

JO - Multiple Sclerosis

JF - Multiple Sclerosis

SN - 1352-4585

IS - 2

ER -